Down -24.31% in 4 Weeks, Here's Why OPKO Health (OPK) Looks Ripe for a TurnaroundZacks Investment Research • 04/22/25
OPKO Health Announces $100 Million Increase to its Existing Share Repurchase ProgramGlobeNewsWire • 04/04/25
Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services BusinessesPRNewsWire • 03/11/25
OPKO Health (OPK) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 02/28/25
OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial ResultsGlobeNewsWire • 02/27/25
Countdown to OPKO Health (OPK) Q4 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research • 02/25/25
NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition ExpoPRNewsWire • 11/18/24
NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 ResultsPRNewsWire • 11/14/24
OPK Stock Gains Following Q3 Earnings Beat, Gross Margin ContractsZacks Investment Research • 11/08/24
Here's What Key Metrics Tell Us About OPKO Health (OPK) Q3 EarningsZacks Investment Research • 11/08/24
OPK Gets Additional BARDA Funding to Develop Multispecific AntibodiesZacks Investment Research • 10/11/24
ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza ProgramGlobeNewsWire • 10/07/24
NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into JapanPRNewsWire • 10/07/24
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO HealthPRNewsWire • 09/16/24
OPKO Health Reports Second Quarter 2024 Business Highlights and Financial ResultsGlobeNewsWire • 08/07/24